This article will be permanently flagged as inappropriate and made unaccessible to everyone. Are you certain this article is inappropriate? Excessive Violence Sexual Content Political / Social
Email Address:
Article Id: WHEBN0031076802 Reproduction Date:
InChI=1S/C26H26N2O2/c1-19-10-11-23(21-7-3-2-6-20(19)21)26(29)24-18-28(25-9-5-4-8-22(24)25)13-12-27-14-16-30-17-15-27/h2-11,18H,12-17H2,1H3 Key:ICKWPPYMDARCKJ-UHFFFAOYSA-N
JWH-193 is a drug from the aminoalkylindole family which acts as a cannabinoid receptor agonist. It was invented by the pharmaceutical company Sanofi-Winthrop in the early 1990s. JWH-193 has a binding affinity at the CB1 receptor of 6nM, binding around seven times more tightly than the parent compound JWH-200,[1] though with closer to twice the potency of JWH-200 in activity tests. A structural isomer of JWH-193 with the methyl group on the indole ring instead of the naphthoyl ring, was also found to be of similarly increased potency over JWH-200.[2][3]
Diamond, Graphite, Solar system, Coal, /anolanthanide Chemistry
Oxygen, Argon, Hydrogen, Helium, Gold
Nitrogen, Hydrogen, Helium, Sulfur, Fluorine
Database, Chemistry, PubMed, American Chemical Society, National Center for Biotechnology Information
Carbon, Hydrogen, Nitrogen, Oxygen, ChemSpider
Carbon, Hydrogen, Nitrogen, Oxygen, PubChem
Carbon, Hydrogen, Nitrogen, Oxygen, Jwh-081
Xenon, Carbon, Hydrogen, Oxygen, Tetrahydrocannabinol